Not a good buy right now for an impatient trader: price is pushing into nearby resistance with momentum getting stretched, while fundamentals recently weakened.
If you already own it, the trend is still constructive short-term, but the upside is likely capped near 8.38–8.59 unless a catalyst appears.
If you don’t own it, I would pass on buying at 8.25 pre-market and reassess on either a clean breakout above 8.59 or a pullback toward ~8.03/7.68 support.
Momentum: MACD histogram is positive (0.0158) and expanding, supporting near-term continuation.
Overbought risk: RSI(6) ~69.93 is close to overbought, suggesting limited immediate upside and higher pullback risk.
Key levels: Pivot 8.03; resistance R1 8.376 (very close to current 8.25), then R2 8.59; support S1 7.68 then S2 7.466.
Practical read: Buying here is “buying into resistance” rather than into support, which is a poor entry for someone unwilling to wait.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open interest put-call ratio 0.08 is extremely call-heavy (bullish skew), but today’s volume is tiny (10 contracts), so the signal quality is low.
Volatility: IV(30d) 158.02 vs historical vol 55.17, with IV percentile 99.2 — options are pricing unusually large moves/uncertainty.
Flow: Call volume reported as 0 while put volume is 10; overall activity is sparse, so sentiment inference should be discounted.
Takeaway: Options market is pricing high uncertainty; skew looks bullish but thin liquidity/volume makes it unreliable for timing a buy now.
Wall Street-style cons (based on provided data): deteriorating earnings/EPS; lack of near-term catalysts/news; price entering resistance with stretched momentum.
Wall Street analysts forecast BVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BVS is 15 USD with a low forecast of 15 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BVS is 15 USD with a low forecast of 15 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.210
Low
15
Averages
15
High
15
Current: 8.210
Low
15
Averages
15
High
15
Cantor Fitzgerald
Ross Osborn
Overweight
initiated
$12
AI Analysis
2025-07-07
Reason
Cantor Fitzgerald
Ross Osborn
Price Target
$12
AI Analysis
2025-07-07
initiated
Overweight
Reason
Cantor Fitzgerald analyst Ross Osborn initiated coverage of Bioventus with an Overweight rating and $12 price target.
